Atrys Health, S.A. (ATRY.MC)

EUR 3.11

(0.32%)

Total Debt Summary of Atrys Health, S.A.

Atrys Health, S.A.'s latest annual total debt in 2023 was 254 Million EUR , down -1.83% from previous year.
Atrys Health, S.A.'s latest quarterly total debt in 2024 Q1 was 168.4 Million EUR , down -33.7% from previous quarter.
Atrys Health, S.A. reported annual total debt of 258.73 Million EUR in 2022, up 26.51% from previous year.
Atrys Health, S.A. reported annual total debt of 204.51 Million EUR in 2021, up 186.21% from previous year.
Atrys Health, S.A. reported quarterly total debt of 168.4 Million EUR for 2024 Q1, down -33.7% from previous quarter.
Atrys Health, S.A. reported quarterly total debt of 247.49 Million EUR for 2023 Q3, down -4.33% from previous quarter.

Annual Total Debt Chart of Atrys Health, S.A. (2023 - 2012)

Historical Annual Total Debt of Atrys Health, S.A. (2023 - 2012)

Year	Total Debt	Total Debt Growth
2023	254 Million EUR	-1.83%
2022	258.73 Million EUR	26.51%
2021	204.51 Million EUR	186.21%
2020	71.45 Million EUR	105.33%
2019	34.8 Million EUR	91.3%
2018	18.19 Million EUR	62.61%
2017	11.18 Million EUR	-18.09%
2016	13.65 Million EUR	1.95%
2015	13.39 Million EUR	18.88%
2014	11.26 Million EUR	3.75%
2013	10.86 Million EUR	1.8%
2012	10.67 Million EUR	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	219.42 Million EUR	48.64%
2024 Q1	168.4 Million EUR	-33.7%
2023 Q3	247.49 Million EUR	-4.33%
2023 FY	254 Million EUR	-1.83%
2023 Q1	252.98 Million EUR	-2.22%
2023 Q4	254 Million EUR	2.63%
2023 Q2	258.68 Million EUR	2.25%
2022 Q1	235.79 Million EUR	15.3%
2022 FY	258.73 Million EUR	26.51%
2022 Q4	258.73 Million EUR	10.68%
2022 Q3	233.77 Million EUR	-3.28%
2022 Q2	241.69 Million EUR	2.5%
2021 Q4	204.51 Million EUR	5.21%
2021 Q1	179.84 Million EUR	151.68%
2021 FY	204.51 Million EUR	186.21%
2021 Q2	184.89 Million EUR	2.81%
2021 Q3	194.38 Million EUR	5.13%
2020 Q2	39.23 Million EUR	1.66%
2020 Q4	71.45 Million EUR	1.1%
2020 Q1	38.59 Million EUR	10.89%
2020 FY	71.45 Million EUR	105.33%
2020 Q3	70.68 Million EUR	80.16%
2019 FY	34.8 Million EUR	91.3%
2019 Q2	20.66 Million EUR	2.04%
2019 Q4	34.8 Million EUR	-0.85%
2019 Q3	35.1 Million EUR	69.83%
2019 Q1	20.25 Million EUR	11.34%
2018 Q4	18.19 Million EUR	1.99%
2018 FY	18.19 Million EUR	62.61%
2018 Q2	1.8 Million EUR	-84.92%
2018 Q1	11.97 Million EUR	7.02%
2018 Q3	17.83 Million EUR	887.65%
2017 FY	11.18 Million EUR	-18.09%
2017 Q4	11.18 Million EUR	-11.82%
2017 Q3	12.68 Million EUR	-5.56%
2017 Q2	13.43 Million EUR	1.18%
2017 Q1	13.27 Million EUR	-2.79%
2016 Q2	2.16 Million EUR	0.16%
2016 Q1	2.16 Million EUR	0.0%
2016 FY	13.65 Million EUR	1.95%
2016 Q4	13.65 Million EUR	1.3%
2016 Q3	13.48 Million EUR	521.58%
2015 FY	13.39 Million EUR	18.88%
2014 FY	11.26 Million EUR	3.75%
2013 FY	10.86 Million EUR	1.8%
2012 FY	10.67 Million EUR	0.0%

Peer Total Debt Comparison of Atrys Health, S.A.

Name	Total Debt	Total Debt Difference
Biotechnologies Assets SA	7.12 Million EUR	-3464.52%
Pharma Mar, S.A.	43.36 Million EUR	-485.685%
Laboratorios Farmaceuticos Rovi, S.A.	65.42 Million EUR	-288.219%